IRIS
SIMONE, Isabella Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.371
AS - Asia 5.494
EU - Europa 4.465
SA - Sud America 1.453
Continente sconosciuto - Info sul continente non disponibili 833
AF - Africa 261
OC - Oceania 10
Totale 28.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.990
SG - Singapore 2.070
IT - Italia 1.544
CN - Cina 1.157
BR - Brasile 1.145
HK - Hong Kong 1.083
SE - Svezia 535
DE - Germania 434
RU - Federazione Russa 419
UA - Ucraina 347
FI - Finlandia 329
FR - Francia 322
VN - Vietnam 308
GB - Regno Unito 230
CA - Canada 179
IN - India 167
BD - Bangladesh 166
AR - Argentina 93
IQ - Iraq 83
CI - Costa d'Avorio 69
ID - Indonesia 65
TR - Turchia 53
ZA - Sudafrica 53
EC - Ecuador 46
CO - Colombia 45
PK - Pakistan 41
BE - Belgio 39
MX - Messico 37
ES - Italia 35
JP - Giappone 35
PL - Polonia 35
VE - Venezuela 35
IE - Irlanda 34
LT - Lituania 32
MA - Marocco 31
UZ - Uzbekistan 31
NL - Olanda 30
PH - Filippine 29
CR - Costa Rica 27
SA - Arabia Saudita 27
AT - Austria 24
AE - Emirati Arabi Uniti 23
CL - Cile 23
UY - Uruguay 22
GT - Guatemala 21
MY - Malesia 21
HN - Honduras 20
JO - Giordania 19
JM - Giamaica 18
SV - El Salvador 18
IL - Israele 16
NI - Nicaragua 16
PY - Paraguay 15
SC - Seychelles 15
TN - Tunisia 15
BO - Bolivia 14
CW - ???statistics.table.value.countryCode.CW??? 14
KE - Kenya 14
TT - Trinidad e Tobago 14
OM - Oman 13
ET - Etiopia 12
PE - Perù 12
AZ - Azerbaigian 10
PR - Porto Rico 10
BG - Bulgaria 8
EG - Egitto 8
NG - Nigeria 8
RO - Romania 8
AU - Australia 7
EU - Europa 7
KZ - Kazakistan 7
NP - Nepal 7
PT - Portogallo 7
RS - Serbia 7
AO - Angola 6
BY - Bielorussia 6
DZ - Algeria 6
GE - Georgia 6
IR - Iran 6
KW - Kuwait 6
TH - Thailandia 6
TW - Taiwan 6
EE - Estonia 5
GP - Guadalupe 5
GR - Grecia 5
LB - Libano 5
SN - Senegal 5
AL - Albania 4
BH - Bahrain 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
GA - Gabon 4
KG - Kirghizistan 4
KR - Corea 4
LV - Lettonia 4
AM - Armenia 3
BB - Barbados 3
BZ - Belize 3
CH - Svizzera 3
MD - Moldavia 3
Totale 28.023
Salva come PNG Salva come JPEG
Città #
Ashburn 1.816
Fairfield 1.523
Woodbridge 1.171
Singapore 1.093
San Jose 923
Chandler 901
Houston 820
Jacksonville 788
Seattle 643
Hong Kong 610
Wilmington 558
Milan 537
Cambridge 529
Ann Arbor 488
Nyköping 369
Council Bluffs 365
New York 295
Beijing 282
Los Angeles 230
Lawrence 224
Roxbury 224
Dallas 213
Lauterbourg 207
Nanjing 180
Boardman 159
Rome 155
Des Moines 150
Santa Clara 126
Helsinki 124
Columbus 106
São Paulo 105
Ho Chi Minh City 104
Bari 103
Princeton 96
Brooklyn 78
San Diego 77
Abidjan 69
Nanchang 63
Turin 63
Munich 61
Inglewood 60
San Francisco 58
Hanoi 56
London 56
Hebei 55
Orem 52
Buffalo 51
Dearborn 51
Jiaxing 50
Denver 49
Atlanta 48
Shenyang 48
Figino 47
Chicago 44
Rio de Janeiro 44
Frankfurt am Main 41
Montreal 40
Tianjin 39
Falls Church 38
North Bergen 38
Brussels 37
Dong Ket 36
Belo Horizonte 35
Paris 35
Phoenix 35
Toronto 34
Tokyo 33
Dublin 32
Marseille 31
Washington 31
Norwalk 30
Baghdad 29
Jakarta 29
Changsha 28
Moscow 26
Tashkent 26
Warsaw 26
Boston 24
Redwood City 24
Brasília 23
Guangzhou 23
Nuremberg 23
Pune 23
Charlotte 22
Naples 22
The Dalles 22
Johannesburg 21
Florence 20
Shanghai 20
Clifton 19
Curitiba 19
Falkenstein 18
Quito 18
Secaucus 18
San José 17
Chennai 16
Guayaquil 16
Istanbul 16
Lahore 16
Managua 16
Totale 18.582
Salva come PNG Salva come JPEG
Nome #
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.J Neurol Sci. 2001 Jan 1;182(2):143-50 688
Adherence to riluzole in patients with amyotrophic lateral sclerosis: An observational study 679
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis 380
Corrigendum: Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 252
Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 237
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS 222
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 206
Convexal subarachnoid hemorrhage and acute ischemic stroke: a border zone matter? 203
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 203
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 201
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 196
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 194
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 192
Assisting persons with advanced amyotrophic lateral sclerosis in their leisure engagement and communication needs with a basic technology-aided program 190
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 182
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 180
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 179
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience 177
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 175
Multiparametric unconventional MRI study in early stage of ALS disease 171
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 169
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 161
BRAIN CORTEX THINNING IN MOTOR AND EXTRA-MOTOR AREAS IN AMYOTROPHIC LATERAL SCLEROSIS 159
Double-Blind Placebo-Controlled Trial on the Use of Acetyl-L-Carnitine for the Treatment of Amyotrophic Lateral Sclerosis (P04.151) 158
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 155
The role of imaging in Hirayama disease 154
Hirayama disease: the importance of an early diagnosis 153
Predictors of long survival in amyotrophic lateral sclerosis: A population-based study 153
Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype 151
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 150
A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids 150
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 150
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 148
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 148
MR evaluation of encephalic leukoaraiosis in sudden sensorineural hearing loss (SSNHL) patients 147
Intrathecal immune response in human immunodeficiency virus infection 145
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy 145
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial) 143
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. 141
Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients? 140
Verbal Learning Abilities in ALS Patients (P01.109) 140
Is Frontal Assessment Battery a useful instrument to detect cognitive impairment in ALS?. 139
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study. 139
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD 137
N-Acetyl-Aspartate (NAA) and Neurofilament-Light Chain (NF-L) in biological fluids as markers of neurodegeneration in ALS 136
Elevated plasma homocystein levels in patients with Amyotrophic lteral sclerosis 136
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 136
1H-MR Spectroscopy profiles in normal appearing white matter(NAWM) of clinically isolated sindromes suggestive of multiple sclerosis(CIS) 136
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study 134
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy 134
Brain Cortex Thinning in Motor And Extra-motor Areas in Amyotrophyc Lateral Sclerosis 133
HFE p.H63D polymorphism does not influence ALS phenotype and survival 132
Long term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience 131
Brain cortex thinning in motor and extra-motor areas in amyotrophic lateral sclerosis 127
1H-MRSA comparison of normal appearing white matter in different clinical MS subgroups 127
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 124
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled,multicentre clinical trial for colchicine in ALS (Co-ALS) 124
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues 123
Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. 121
High resolution proton MR-spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques 120
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 119
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 119
99mTc-HM-PAO SPET and proton magnetic resonance spectroscopy in patients with ischaemic cerebral infarction 118
Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis. 118
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 116
Prognostic factors in ALS: A critical review 115
Alzheimer disease: comparison of 99mTc-HMPAO SPET and 1H-MRS data 115
99Tcm-HMPAO SPET and 1H-MRS (Proton Magnetic Resonance Spectroscopy) in patients with ischaemic cerebral infarction 115
Relationships between regional cortical atrophy and cognitive dysfunction in non-demented ALS patients 114
Sintesi intratecale di IgG in corso di infezioni da HIV 114
Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2007 Feb;28(2):255-9 113
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 113
Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels in ALS Patients 112
Life-threatening ADEM in an immunocompetent pregnant woman with concomitant asymptomatic Cytomegalovirus infection 112
Isoelectric focusing and crossed immunoelectrofocusing of cerebrospinal fluid proteins in neurological disorders 112
Incidence of amyotrophic lateral sclerosis in Europe 111
A 71-nucleotide deletion in the periaxin gene in an Italian patient with late-onset slowly progressive demyelinating CMT 111
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 110
Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian cases 109
dentification of a point mutation impairing the binding between Aquaporin-4 and the Neuromyelitis Optica autoantibodies 108
Intra blood-barrier (BBB) immune rersponse in HIV-infected patients 107
. Amyotrophic lateral sclerosis: a new missense mutation in the SOD1 gene 106
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP). 105
Intrathecal IgG synthesis and clinical course in Multiple Sclerosis 105
A case of Landau-Kleffner syndrome secondary to inflammatory demyelinating disease 105
Early onset multiple sclerosis 105
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy 104
Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes 103
Intra blood-brain barrier (BBB) immune rersponse and clinical course in Multiple Sclerosis 102
The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis. 102
Cognitive impairment and regional cortical atrophy in Amyotrophic lateral sclerosis 101
Brain cortical thinning in Motor and Extra-motor areas in Amyotrophic Lateral Sclerosis 101
null 101
Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation 101
null 100
Serum N-Acetyl-Aspartate Levels in Amyotrophic Lateral Sclerosis 100
Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study 100
Benign and malignant MS:clinical and 1H-MRS parameters associated with different MS courses 99
Disease duration, relapse rate and clinical course in Multiple Sclerosis. Relation to IgG production wthin the blood-brain barrier.Intrathecal immune response in human immunodeficiency virus infection 99
CA-ACTIVATED PROTEOLYSIS OF MYELIN BASIC-PROTEIN - AN IMMUNOLOGICAL STUDY 99
Totale 15.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.692 0 0 0 0 82 172 46 72 99 110 262 849
2022/20232.261 365 220 157 211 293 255 32 249 393 14 40 32
2023/2024809 57 153 51 39 54 232 21 34 18 21 5 124
2024/20253.356 107 65 322 119 88 285 207 274 173 194 491 1.031
2025/20268.042 1.070 279 410 718 660 431 943 245 660 724 925 977
2026/20272.962 348 447 843 1.204 120 0 0 0 0 0 0 0
Totale 28.887